Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New technique in permanent bradytherapy for the treatment of lung cancer

09.07.2004


The University Hospital at Navarre University has developed a system for the percutaneous implantation of palladium 103 seeds, a new technique in permanent bradytherapy for the treatment of lung cancer. Recently, the fourth experiment was carried out and the results remitted to the scientific magazine, "Bradytherapy", for its publication. To date there has been no description in world scientific literature of any case using this therapeutic procedure.



The Clínica Universitaria has hosted the only cases of bradytherapy using palladium implantation although, in the literature, there exist two articles on the treatment of 8 patients with iodine 125, a radioisotope especially suited to treatment of prostate cancer. In this case it was decided to opt for palladium 103 given that theoretically it adapts better to rapid and aggressive growth lesions such as the majority of primary lung tumours – although this affirmation is not backed up by clinical data. Apart from this, the isotope having a shorter half-life, the radiological protection measures are reduced.

Bradytherapy is a radical radiation technique which is undertaken jointly by the Radiology and Oncology Departments at the University Hospital. It involves the percutaneous implantation of radioactive seeds by means of vectors that are placed inside the tumour. The procedure is carried out under a general anaesthetic with the patient lying on their back. First, the radiologist selects the target area and then the vectors are introduced with the point guided by CAT (computer-controlled axial tomography); in this way the structures through which they pass can be seen in practically real time. Once it is confirmed that the vectors are correctly placed into position, the radioactive load is impanted.


Suitability

Bradytherapy with palladium 103 is suitable for those persons with small lesions which, because they are deemed medically unsuitable (because of age, accompanying illnesses, limited pulmonary capacity, etc.), cannot be subjected to open surgery involving the resection of lung tissue. They are very select, high-risk patients who have tumours accessible at the point of puncture by an external route. Until now, the only alternative therapy available to these patients has been external radiation. Nevertheless, this treatment has the drawback of lasting possibly weeks, whereas Bradytherapy is carried out in just one day.

The results obtained with this technique are very satisfactory although not definitive, given the short period of monitoring. Apart from these data, in the opinion of Dr. Martínez-Monge, Bradytherapy has demonstrated its success as a therapeutic option for this group of patients who cannot undergo surgery.

Given that the implantation of palladium 103 is carried out in a percutaneous manner, this technique provides the advantage of a rapid recovery without pain. Moreover, the only two possible complications (pneumothorax, i.e. entry of air into the thoracic cavity and the risk of bleeding) are verified in situ, which allows a rapid response. In any case, none of the patients treated with this procedure has shown these complications nor have others been observed.

Garazi Andonegi | Basque Research
Further information:
http://www.unav.es

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>